Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
19-21-1|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-238 dioxide,Quantity:24.4,Unit:kilobecquerels,Application:Inhalation, Remarks:initial lung content size < 1µm|18 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Rat sacrificed 60 and 90 days, and also post-mortem for lung pathology and Pu distribution|No information on individuals available for this study
19-21-2|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-238 dioxide,Quantity:375,Unit:kilobecquerels,Application:Inhalation, Remarks:initial lung content size < 1µm|17 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Rat sacrificed 60 and 90 days, and also post-mortem for lung pathology and Pu distribution|No information on individuals available for this study
19-21-3|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-238 dioxide,Quantity:50.5,Unit:becquerels initial or established lung burden,Application:Inhalation, Remarks:initial lung content size < 1µm|22 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Rat sacrificed 60 and 90 days, and also post-mortem for lung pathology and Pu distribution|No information on individuals available for this study
19-21-4|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-238 dioxide,Quantity:11.5,Unit:kilobecquerels,Application:Inhalation, Remarks:initial lung content size < 1µm|63 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Rat sacrificed 6,9,12,15,18 months and post-mortem for lung pathology and Pu distribution|No information on individuals available for this study
19-21-5|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 citrate,Quantity:11.1,Unit:kilobecquerels,Application:Inhalation, Remarks:initial lung content size ~ 1µm|81 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Rat sacrificed 6,9,12,15,18 months and post-mortem for lung pathology and Pu distribution|No information on individuals available for this study
19-21-5|n/a,n/a|Sequence:2, Age:n/a,Type:Undefined,Quantity:,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:n/a|81 (0 in ERA)|Rat|Rat Wistar|Female|Young Adult|Rat sacrificed 6,9,12,15,18 months and post-mortem for lung pathology and Pu distribution|No information on individuals available for this study
		
